+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Urinary Tract Infection Testing Market - Global Forecast 2026-2032- Product Image
Urinary Tract Infection Testing Market - Global Forecast 2026-2032- Product Image
New

Urinary Tract Infection Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666357
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The urinary tract infection testing market is being rapidly reshaped by clinical needs, operational demands, and commercial pressures, requiring decision-makers to adapt strategies as technologies and care models evolve.

Market Snapshot

The Urinary Tract Infection Testing Market is experiencing significant growth, valued at USD 1.41 billion in 2025 and expected to reach USD 1.51 billion in 2026. With a projected CAGR of 6.87%, the market will continue its upward trajectory to achieve USD 2.25 billion by 2032. This expansion is propelled by advances in molecular diagnostics, increasing automation, and rising demand for decentralized, rapid, and high-accuracy testing solutions that support both clinical and operational priorities for healthcare providers and laboratories.

Scope & Segmentation

This report provides a rigorous analysis of the urinary tract infection testing market across multiple dimensions, ensuring optimal alignment with both strategic procurement and market entry decisions:

  • Test Types: Automated Urinalysis (including Microscopy, Digital Imaging, Flow Cytometry), Culture Test, Molecular Test (Isothermal Amplification, Next Generation Sequencing, PCR Assay), and Rapid Test formats (Dipstick, Microscopy).
  • Technological Platforms: Automated Systems (Fully and Semi-Automated), Culture-Based Workflows, Immunoassays (Chemiluminescent, ELISA, Lateral Flow Assay), Molecular Diagnostics (Isothermal, NGS, PCR).
  • End Users: Hospitals, Diagnostic Laboratories, Clinics, Home Care providers.
  • Distribution Channels: Direct Tender, E-Commerce, Hospital Pharmacy, Retail Pharmacy.
  • Sample Types: Catheterized, Midstream Clean Catch, Suprapubic Aspiration specimens.
  • Regions Analyzed: Americas, Europe, Middle East & Africa, Asia-Pacific.

Segment insights enable executive teams to calibrate offerings and channel strategies for distinctive care environments and regulatory landscapes.

Key Takeaways

  • Technological convergence is accelerating diagnostic migration from centralized labs to near-patient and home settings, reshaping care delivery pathways.
  • Molecular and digital diagnostic platforms are enhancing both speed and accuracy, driving integration with electronic health records and antimicrobial stewardship initiatives.
  • Automation reduces labor intensity and supports higher throughput requirements, while new rapid formats expand access and suitability for outpatient and remote environments.
  • Supply chain resilience has become a strategic focus as organizations adopt localization, diversify sourcing, and establish regional partnerships to navigate input volatility.
  • Product portfolios must be flexible to accommodate distinct sample types and end-user needs, from advanced analytics in laboratories to immediate results in clinics and home care.

Tariff Impact on Supply Chain and Procurement

Recent U.S. tariff changes have increased costs for imported instruments and consumables, affecting procurement behavior and margin structures across the urinary tract infection diagnostics sector. Leading companies are responding by redesigning supply chains, localizing production where feasible, and entering collaborative purchasing agreements to stabilize input costs and ensure service continuity. These tactical adaptations support sustained access and address delivery constraints exacerbated by cross-border policy shifts.

Methodology & Data Sources

The report is built on a transparent, reproducible process integrating primary interviews with laboratory directors, clinicians, and procurement leaders, alongside secondary synthesis of literature, regulatory documents, and corporate disclosures. Triangulated insights and segment testing ensure relevancy and robustness, with quality-control checks to surface biases or rapid changes in technology and procurement ecosystems.

Why This Report Matters

  • Enables manufacturers and healthcare providers to align product development with real-world workflow and procurement realities.
  • Delivers actionable market segmentation and regional guidance for enhanced go-to-market strategy and channel targeting.
  • Supports informed responses to evolving regulatory, tariff, and care delivery demands across global diagnostic ecosystems.

Conclusion

Technology innovation, resilient supply strategy, and precise segmentation are now pivotal to competitive positioning. Organizations that combine operational agility with clear clinical value and effective channel alignment will pace market leadership as the urinary tract infection diagnostics landscape continues to transform.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Urinary Tract Infection Testing Market, by Test Type
8.1. Automated Urinalysis
8.1.1. Automated Microscopy
8.1.2. Digital Imaging
8.1.3. Flow Cytometry
8.2. Culture Test
8.3. Molecular Test
8.3.1. Isothermal Amplification
8.3.2. Next Generation Sequencing
8.3.3. Pcr Assay
8.4. Rapid Test
8.4.1. Dipstick Test
8.4.2. Microscopy
9. Urinary Tract Infection Testing Market, by Technology
9.1. Automated Systems
9.1.1. Fully Automated
9.1.2. Semi Automated
9.2. Culture Based
9.3. Immunoassays
9.3.1. Chemiluminescent Immunoassay
9.3.2. Elisa
9.3.3. Lateral Flow Assay
9.4. Molecular Diagnostics
9.4.1. Isothermal
9.4.2. Next Generation Sequencing
9.4.3. Pcr
10. Urinary Tract Infection Testing Market, by Sample Type
10.1. Catheterized
10.2. Midstream Clean Catch
10.3. Suprapubic Aspiration
11. Urinary Tract Infection Testing Market, by End User
11.1. Clinics
11.2. Diagnostic Laboratories
11.3. Home Care
11.4. Hospitals
12. Urinary Tract Infection Testing Market, by Distribution Channel
12.1. Direct Tender
12.2. E Commerce
12.3. Hospital Pharmacy
12.4. Retail Pharmacy
13. Urinary Tract Infection Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Urinary Tract Infection Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Urinary Tract Infection Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Urinary Tract Infection Testing Market
17. China Urinary Tract Infection Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Accelerate Diagnostics, Inc.
18.7. ACON Laboratories, Inc.
18.8. Beckman Coulter, Inc. by Danaher Corporation
18.9. Bio-Rad Laboratories, Inc.
18.10. bioMérieux SA
18.11. Cardinal Health Inc.
18.12. Chungdo Pharm Co., Ltd.
18.13. F. Hoffmann-La Roche Ltd.
18.14. Genetworx, LLC
18.15. Module Innovations Pvt. Ltd.
18.16. Piramal Pharma Limited
18.17. QIAGEN GmbH
18.18. Randox Laboratories Ltd.
18.19. Siemens Healthineers
18.20. Stryker Corporation
18.21. SYSMEX CORPORATION
18.22. T2 Biosystems, Inc.
18.23. Thermo Fisher Scientific Inc.
18.24. Vivosens Inc.
List of Figures
FIGURE 1. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIGITAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIGITAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIGITAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIPSTICK TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIPSTICK TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIPSTICK TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MICROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MICROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SEMI AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SEMI AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SEMI AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY ISOTHERMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CATHETERIZED, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CATHETERIZED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CATHETERIZED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MIDSTREAM CLEAN CATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MIDSTREAM CLEAN CATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY MIDSTREAM CLEAN CATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUPRAPUBIC ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUPRAPUBIC ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUPRAPUBIC ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIRECT TENDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIRECT TENDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 171. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 172. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 177. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. EUROPE URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 193. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 194. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 195. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 196. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 198. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 199. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 200. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 201. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 219. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 220. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 221. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 223. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 224. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 225. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 226. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. ASEAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 230. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 231. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 232. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 233. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 235. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 236. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 237. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 238. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. GCC URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 254. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 255. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 256. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 257. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 259. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 260. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 261. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 262. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. BRICS URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 264. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 266. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 267. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 268. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 269. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 270. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 271. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 272. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 273. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 274. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. G7 URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 276. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 278. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 279. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 280. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 281. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 282. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, 2018-2032 (USD MILLION)
TABLE 283. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 284. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 285. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 286. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. NATO URINARY TRACT INFECTION TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY AUTOMATED URINALYSIS, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY RAPID TEST, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES URINARY TRACT INFECT

Companies Mentioned

The key companies profiled in this Urinary Tract Infection Testing market report include:
  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cardinal Health Inc.
  • Chungdo Pharm Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Genetworx, LLC
  • Module Innovations Pvt. Ltd.
  • Piramal Pharma Limited
  • QIAGEN GmbH
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Stryker Corporation
  • SYSMEX CORPORATION
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.
  • Vivosens Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.51 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.25 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Urinary Tract Infection Market - Global Forecast 2026-2032 - Product Image

Urinary Tract Infection Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Urinary Tract Infection Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Urinary Tract Infection Testing Devices Market Report 2025 - Product Image

Urinary Tract Infection Testing Devices Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Urinary Tract Infection Testing Market - Global Strategic Business Report - Product Image

Urinary Tract Infection Testing Market - Global Strategic Business Report

  • Report
  • 300 Pages
  • Global
From
Urinary Tract Infection Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Urinary Tract Infection Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 134 Pages
  • Global
From

About the Urinary Tract Infection Testing Market

The Urinary Tract Infection (UTI) Testing market is a subset of the Urology and Nephrology industry. It is focused on the diagnosis and treatment of UTIs, which are caused by bacteria entering the urinary tract. UTI testing is used to identify the presence of bacteria in the urine, as well as to determine the type of bacteria present. Tests may include urine cultures, urine microscopy, and urine antigen tests. Treatment typically involves antibiotics, and in some cases, surgery. The UTI Testing market is driven by the increasing prevalence of UTIs, as well as the need for accurate diagnosis and treatment. The market is expected to grow in the coming years, as new technologies and treatments are developed. Some companies in the UTI Testing market include Siemens Healthineers, Abbott Laboratories, Becton Dickinson, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.